Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery
- 1 October 1997
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 122 (3) , 431-438
- https://doi.org/10.1038/sj.bjp.0701397
Abstract
The aim of the present study was to investigate in rat mesenteric artery rings whether low concentrations of vasopressin could modify the contractile responses to noradrenaline and electrical stimulation of perivascular nerves. Vasopressin (10−10–10−7 M) caused concentration‐dependent contractions (pD2=8.36±0.09). The V1‐receptor antagonist d(CH2)5Tyr(Me)AVP (10−9–10−8 M) produced parallel rightward shifts of the control curve for vasopressin. Schild analysis yielded a pA2 value of 9.83 with a slope of 1.10±0.14. Vasopressin (3×10 −10 and 10−9 M) caused concentration‐dependent potentiation of the contractions elicited by electrical stimulation (2–8 Hz; 0.2 ms duration for 30 s) and produced leftward shifts of the concentration‐response curve for noradrenaline. The V1‐receptor antagonist induced concentration‐dependent inhibitions of potentiation induced by vasopressin. The selective V1‐receptor agonist [Phe*, Orn8]‐vasotocin (3×10 −10 and 10−9 M) induced potentiation of electrical stimulation‐evoked responses which was also inhibited in the presence of the V1 antagonist (10−8 M). In contrast, the V2‐receptor agonist deamino‐8‐D‐arginine vasopressin (desmopressin 10−8–10−7 M) did not modify the electrical stimulation‐induced responses and the V2‐receptor antagonist [d(CH2)5, D‐Ile*, Ile4, Arg8]‐vasopressin (10−8–10−7 M) did not affect the potentiation evoked by vasopressin. In artery rings contracted by 10−6 M noradrenaline in the presence of 10−6 M guanethidine and 10−6 M atropine, electrical stimulation (2, 4 and 8 Hz) produced frequency‐dependent relaxations which were unaffected by 10−9 M vasopressin but abolished by 10−6 M tetrodotoxin. Vasopressin also potentiated contractions elicited by KCl and contractions induced by addition of CaCl2 to KCl depolarized vessels. The augmenting effects were inhibited by the V1 antagonist. In the presence of the calcium antagonist nifedipine (10−6 M), vasopressin failed to enhance the contractile responses to electrical stimulation, noradrenaline and KCl. The results demonstrate that low concentrations of vasopressin strongly potentiate the contractions to adrenergic stimulation and KCl depolarization. This effect appears to be mediated by V1 receptor stimulation which brings about an increase in calcium entry through dihydropyridine‐sensitive calcium channels. British Journal of Pharmacology (1997) 122, 431–438; doi:10.1038/sj.bjp.0701397Keywords
This publication has 27 references indexed in Scilit:
- Regional differences in the arterial response to vasopressin: role of endothelial nitric oxideBritish Journal of Pharmacology, 1996
- Characterization of arginine vasopressin actions in human uterine artery: lack of role of the vascular endotheliumBritish Journal of Pharmacology, 1995
- Relaxation of human isolated mesenteric arteries by vasopressin and desmopressinBritish Journal of Pharmacology, 1994
- Angiotensin II facilitates sympathetic transmission in rat hind limb circulation.Hypertension, 1993
- Arginine vasopressin attenuates phenylephrine-induced forearm vasoconstriction in menClinical Science, 1991
- Characterization of vasopressin actions in isolated submucosal arterioles of the intestinal microcirculation.Circulation Research, 1990
- Aminergic histofluorescence and contractile responses to transmural electrical field stimulation and norepinephrine of human middle cerebral arteries obtained promptly after death.Circulation Research, 1989
- Hormonal Stimulation of Phosphatidylinositol Breakdown, with Particular Reference to the Hepatic Effects of VasopressinBiochemical Society Transactions, 1979
- CARDIOVASCULAR ACTIONS OF VASOPRESSINJapanese Circulation Journal, 1973
- SOME QUANTITATIVE USES OF DRUG ANTAGONISTSBritish Journal of Pharmacology and Chemotherapy, 1959